249 related articles for article (PubMed ID: 1693592)
41. Immunocytochemical study of small round cell tumors in routinely processed specimens.
Chang TK; Li CY; Smithson WA
Arch Pathol Lab Med; 1989 Dec; 113(12):1343-8. PubMed ID: 2556086
[TBL] [Abstract][Full Text] [Related]
42. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
43. CD30+ anaplastic large-cell lymphoma with aberrant expression of CD13: case report and review of the literature.
Dunphy CH; Gardner LJ; Manes JL; Bee CS; Taysi K
J Clin Lab Anal; 2000; 14(6):299-304. PubMed ID: 11138613
[TBL] [Abstract][Full Text] [Related]
44. The leukocyte-common antigen (CD45) complex and B-lymphocyte activation.
Zola H; Melo JV; Zowtyj HN; Nikoloutsopoulos A; Skinner J
Hum Immunol; 1990 Apr; 27(4):368-77. PubMed ID: 2138599
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).
Horejsí V; Angelisová P; Bazil V; Kristofová H; Stoyanov S; Stefanová I; Hausner P; Vosecký M; Hilgert I
Folia Biol (Praha); 1988; 34(1):23-34. PubMed ID: 2968928
[TBL] [Abstract][Full Text] [Related]
46. CD30 expression in follicular lymphoma.
Piris M; Gatter KC; Mason DY
Histopathology; 1991 Jan; 18(1):25-9. PubMed ID: 1849500
[TBL] [Abstract][Full Text] [Related]
47. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.
Pulido R; Schlossman SF; Saito H; Streuli M
J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359
[TBL] [Abstract][Full Text] [Related]
48. Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
Zhou M; Fadlelmola FM; Cohn JB; Skinnider B; Gascoyne RD; Banerjee D
Mol Cancer; 2008 Jan; 7():12. PubMed ID: 18218123
[TBL] [Abstract][Full Text] [Related]
49. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
Wieczorek R; Buck D; Bindl J; Knowles DM
Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
[TBL] [Abstract][Full Text] [Related]
50. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G
Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293
[TBL] [Abstract][Full Text] [Related]
51. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
52. Differential effects of CD45 CD45R and CD45R0 monoclonal antibodies in modulating human B cell activation.
Deane DL; Harvey E; Steel CM
Clin Exp Immunol; 1991 Jan; 83(1):175-81. PubMed ID: 1703055
[TBL] [Abstract][Full Text] [Related]
53. Determination of the specificity of CD45 and CD45R monoclonal antibodies through the use of transfected hamster cells producing individual porcine CD45 isoforms.
Schnitzlein WM; Zuckermann FA
Vet Immunol Immunopathol; 1998 Jan; 60(3-4):389-401. PubMed ID: 9589575
[TBL] [Abstract][Full Text] [Related]
54. Leu-22 (L60). A more sensitive marker than UCHL1 for peripheral T-cell lymphomas, particularly large-cell types.
Macon WR; Casey TT; Kinney MC; Collins RD; Cousar JB
Am J Clin Pathol; 1991 May; 95(5):696-701. PubMed ID: 1827236
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings.
Ngan BY; Picker LJ; Medeiros LJ; Warnke RA
Am J Clin Pathol; 1989 May; 91(5):579-83. PubMed ID: 2718958
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
57. Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines.
Nakano A; Harada T; Morikawa S; Kato Y
Acta Pathol Jpn; 1990 Feb; 40(2):107-15. PubMed ID: 2140233
[TBL] [Abstract][Full Text] [Related]
58. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases.
Chott A; Kaserer K; Augustin I; Vesely M; Heinz R; Oehlinger W; Hanak H; Radaszkiewicz T
Am J Surg Pathol; 1990 May; 14(5):439-48. PubMed ID: 2158242
[TBL] [Abstract][Full Text] [Related]
59. Ki-1 positive (anaplastic, large cell) lymphoma (case reports and review).
Kopper L; Rényi I; Pápay J; Kardos G; Bánkfalvi A; Bartók M; Rákóczy G
Acta Paediatr Hung; 1992; 32(3):257-67. PubMed ID: 1335739
[TBL] [Abstract][Full Text] [Related]
60. Intraoral presentation of anaplastic large-cell Ki-1 lymphoma in association with HIV infection.
Hicks MJ; Flaitz CM; Nichols CM; Luna MA; Gresik MV
Oral Surg Oral Med Oral Pathol; 1993 Jul; 76(1):73-81. PubMed ID: 8394561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
